Comparison of the T/NK cell subsets of patients with COVID-19 and controls revealed relative expansion of CD4+ T cells with cytotoxic activity (CD4+ CTLs), CD8+ effector memory T cells (TEM), NK cells, and CD56brightCD16dim NK cells in patients with COVID-19 (Figure 4C). The gene discussed is CD8A; the disease is COVID-19.